跳至主要内容
临床试验/TCTR20230418007
TCTR20230418007Unknown4 期

A pilot study of efficacy and safety of microneedling-assisted topical botulinum toxin A for the treatment of enlarged facial pores: a split-face randomized-controlled pilot study

Faculty of Medicine Siriraj Hospital, Mahidol University0 个研究点目标入组 25 人开始时间: 2023年4月18日最近更新:
适应症

试验速览

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 Years 至 50 Years(—)
性别
All

入选标准

  • 1. Thai descendants
  • 2. There are enlarged pores on both cheeks. By definition, enlarged pores must be visible to the naked eye (visible topographic enlarged facial pores) at a distance of 30 cm and examined by two dermatologists with a consensus.

排除标准

  • 1. Pregnant, breastfeeding, or after giving birth for no more than three months or plan to become pregnant during six months.
  • 2. Using vitamin A compounds or chemical peeling agents or injecting botulinum toxin on the cheek area in the last six months
  • 3. History of allergy to anesthetics or botulinum toxin
  • 4. History of hypertrophic scars or keloids
  • 5. Open wounds, infected skin, or skin rashes on the face
  • 6. Having underlying diseases such as diabetes, collagen-related disorders, immunodeficiencies, or having an underlying condition that the researcher considers to be unsafe if participating in the program, such as epilepsy
  • 7. History of regularly using steroids or smoking.
  • 8. History of using anticoagulants, antiplatelet agents, or ginkgo leaf extract.
  • 9. Volunteers with an implanted pacemaker with an implanted metallic device.

研究者

相似试验

A pilot study of efficacy and safety of... | 临床试验